With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...
(Web Desk) - The harmful effects of air pollution on health, including an increased risk of cancer, have been well-documented ...
TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but ...
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.
Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the ...
Application error: a client-side exception has occurred (see the browser console for more information).
Srinagar- Head and neck cancers are on the rise in Kashmir, with Srinagar and Anantnag districts showing the highest number ...
Purple Biotech Ltd. (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing ...
BofA Securities, TD Cowen, Stifel, Cantor and William Blair are acting as joint book-running managers for the offering. Wedbush PacGrow, LifeSci Capital, BTIG and Jones are acting as co-managers for ...